Xconomy: Xconomy Forum: Pharma's Bet on Boston Innovation

November 4, 2009 – Agenda

1:15 – 2:00	Registration
2:00 – 2:05	Welcome and Opening Remarks Bob Buderi, Founder and Editor in Chief, Xconomy Michelle Dipp, Head of US CEEDD, GlaxoSmithKline
2:05 – 2:35	Keynote: Biotech and Innovation in Boston Christoph Westphal, CEO, Sirtris; SVP, Centre of Excellence for External Drug Discovery, GlaxoSmithKline
2:35 – 2:50	Innovation Profile: Aileron Therapeutics Joseph Yanchik III,  President and CEO
2:50 – 3:40	Pharma Ventures Jean George, General Partner, Advanced Technology Ventures (moderator) Russell Herndon, President and CEO, Hydra Biosciences Maggie Flanagan LeFlore, Managing Director, MedImmune Ventures Campbell Murray, Managing Director, Novartis Venture Funds Daphne Zohar, Founder and Managing Partner, PureTech Ventures
3:40 – 4:00	Networking Break
4:00 – 4:15	Innovation Profile: Aveo Pharmaceuticals Tuan Ha-Ngoc, President and CEO
4:15 – 4:30	Innovation Profile: Enlight Biosciences David Steinberg, Founding CEO
4:30 – 4:45	Innovation Profile: Merck’s Acquisition of GlycoFi Natarajan Sethuraman, Senior Director, Merck GlycoFi
4:45 – 5:30	Closing Address and Chat Deborah Dunsire, CEO, Millennium: The Takeda Oncology Company Interviewed by Noubar Afeyan, Co-founder, Managing Partner and CEO, Flagship Ventures
5:30 – 7:00	Networking Reception

CLICK HERE FOR MORE DETAILS AND TO REGISTER.